Shareholding disclosure

UBS Group AG

Declared position

10.26%

Threshold

Crossed upwards

Timeline

Published

06.11.2020

Transaction

29.10.2020

Voting rights breakdown

Voting rights acquired10.26%

Voting rights sold2.2%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAKB500064

Beneficial owner

UBS Group AG

Declared address

UBS Group AG, Zürich

Crossing below 5% in voting rights (Section 4.1 and 4.3)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

UBS Group AG

DocMorris AG06.11.2020TAKB500064

Disclosure summary

UBS Group AG disclosed a holding in DocMorris AG on the acquisition side, published by SIX Exchange Regulation on 06.11.2020, at 10.26% of voting rights. Notice category: Single shareholder.

Disclosed position

10.26%

Voting rights acquired

Voting rights acquired10.26%

Voting rights sold2.2%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

UBS Group AG disclosed a holding in DocMorris AG, published on 06.11.2020.

Publication date06.11.2020

Transaction date29.10.2020

Issuing companyDocMorris AG

Beneficial ownerUBS Group AG

Declared addressUBS Group AG, Zürich

CategorySingle shareholder

Voting rights acquired10.26%

Voting rights sold2.2%

Below threshold0%

ExchangeXSWX

Notification IDTAKB500064

Commercial register

CHE-395.345.924

Registered

Zefix record

Conditions

Crossing below 5% in voting rights (Section 4.1 and 4.3)

Source: SIX Exchange Regulation · Publication date: 06.11.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open